Search for Clinical Trial Results

Sponsored By

Pulmonary Arterial Hypertension - 27 Studies Found

Status Study
Completed Study Name: The Early Recognition of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2008-01-24
Interventions: Device: ETED, CPET, RHC exercise tricuspid echo doppler (E
Completed Study Name: Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2008-04-14
Interventions:
  • Drug: macitentan (ACT-064992)

Completed Study Name: Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2009-07-19
Interventions: Drug: Fluoxetine Total dose How to take:
Completed Study Name: 6R-BH4 Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Date: 2007-02-12
Interventions: Drug: sapropterin dihydrochloride (6R-BH4) 2.5 mg/kg/day for two weeks, 5 mg/kg/day for two weeks, 10 mg
Completed Study Name: Coenzyme Q-10 and Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2010-03-19
Interventions:
  • Dietary Supplement: Coenzyme Q-10 in Pulmonary Hypertension subjects

Completed Study Name: Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2007-05-22
Interventions:
  • Drug: Imatinib mesylate Other

Completed Study Name: Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Date: 2007-03-26
Interventions: Drug: Sorafenib 200 mg daily and dose escalated to a maximum of 400 mg twice daily
Completed Study Name: Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2013-07-18
Interventions: Procedure: Resynchronization therapy of right ventricle Right atrio-ventricular resynchronization therap
Terminated Study Name: Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Date: 2010-05-03
Interventions:
  • Drug: Imatinib Participants, w
Completed Study Name: Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Date: 2010-04-02
Interventions:
  • Drug: Selexipag Selexipag 200

Next >>>